Anika Therapeutics, Inc. Operating Leases, Rent Expense
Anika Therapeutics, Inc. (ANIK) reported Operating Leases, Rent Expense of $1.80 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2019-02-27
- Anika Therapeutics, Inc. operating leases, rent expense for fiscal 2018 was $1.80M, a 0.00% change from fiscal 2017.
- Anika Therapeutics, Inc. operating leases, rent expense for fiscal 2017 was $1.80M, a 38.46% increase from fiscal 2016.
- Anika Therapeutics, Inc. operating leases, rent expense for fiscal 2016 was $1.30M, a 0.00% change from fiscal 2015.
- Anika Therapeutics, Inc. operating leases, rent expense for fiscal 2015 was $1.30M, a 7.14% decline from fiscal 2014.
| Period end | Operating Leases, Rent Expense | Operating Leases, Rent Expense 12 month | Operating Leases, Rent Expense 12 month as first filed |
|---|---|---|---|
| 2018-12-31 | $1.80M 10-K · filed 2019-02-27 | ||
| 2017-12-31 | $1.80M 10-K · filed 2019-02-27 | ||
| 2016-12-31 | $1.30M 10-K · filed 2019-02-27 | ||
| 2015-12-31 | $1.30M 10-K · filed 2018-02-27 | ||
| 2014-12-31 | $1.40M 10-K · filed 2017-02-24 | ||
| 2013-12-31 | $1.40M 10-K · filed 2016-03-10 | $1.40M 10-K · filed 2014-03-13 | |
| 2012-12-31 | $2.49M 10-K · filed 2015-03-13 | ||
| 2011-12-31 | $3.48M 10-K · filed 2014-03-13 | ||
| 2010-12-31 | $2.89M 10-K · filed 2013-03-14 | ||
| 2009-12-30 | $1.40M 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |